TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 15:45 · Life Sciences & Drug Development · Psychedelic medicines near approval, will transform mental health treatment
episode briefing
Generating Alpha Podcast

Episode 53: Christian Angermayer - Founder of Apeiron Investment Group

2026-05-11 · 5 company · 3 thematic
sentiment
4 bull0 bear1 neu
speakers
christian angermayer

German serial entrepreneur and investor who co-founded Alnylam Pharmaceuticals at age 20, founded Atai Life Sciences to bring psychedelic medicines to psychiatry, co-founded Compass Pathways, and launched Enhanced Games as a performance-enhancing drug-permitted sports league. Runs family office Apeiron Investment Group.

now playing · Life Sciences & Drug Development
Life Sciences & Drug Developmenttailwindscore 8/10christian angermayer
Psychedelic medicines near approval, will transform mental health treatment
Psilocybin and other psychedelics have near-zero downside when used medically with clinicians; first approvals expected early next year via presidential order, proving 1960s science works i…
Human Performance Enhancementtailwindscore 7/10christian angermayer
Enhanced Games proves medical PEDs aid athlete recovery, shifting moral debate
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games' clinical trial dataset will prove safety and effic…
Longevity & Agingtailwindscore 7/10christian angermayer
Hormone replacement therapy from 30s onward is key longevity intervention
Declining testosterone and estrogen drive aging symptoms; TRT and HRT starting in 30s/40s maintain youthful hormone levels, improving energy, cognition, and physical capacity. Angermayer pe…